Does VAMOROLONE Cause Product dose omission issue? 63 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 63 reports of Product dose omission issue have been filed in association with VAMOROLONE (AGAMREE). This represents 6.7% of all adverse event reports for VAMOROLONE.
63
Reports of Product dose omission issue with VAMOROLONE
6.7%
of all VAMOROLONE reports
1
Deaths
21
Hospitalizations
How Dangerous Is Product dose omission issue From VAMOROLONE?
Of the 63 reports, 1 (1.6%) resulted in death, 21 (33.3%) required hospitalization.
Is Product dose omission issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for VAMOROLONE. However, 63 reports have been filed with the FAERS database.
What Other Side Effects Does VAMOROLONE Cause?
Weight increased (147)
Vomiting (49)
Asthenia (45)
Increased appetite (41)
Condition aggravated (40)
Weight decreased (38)
Headache (35)
Pyrexia (32)
Fall (31)
Abdominal discomfort (30)
What Other Drugs Cause Product dose omission issue?
DUPILUMAB (18,189)
USTEKINUMAB (9,405)
GUSELKUMAB (9,267)
LENALIDOMIDE (8,145)
MEPOLIZUMAB (5,873)
TOFACITINIB (5,646)
VOXELOTOR (5,122)
BELIMUMAB (4,671)
SECUKINUMAB (4,572)
APREMILAST (4,460)
Which VAMOROLONE Alternatives Have Lower Product dose omission issue Risk?
VAMOROLONE vs VANCOMYCIN
VAMOROLONE vs VANDETANIB
VAMOROLONE vs VARDENAFIL
VAMOROLONE vs VARENICLINE
VAMOROLONE vs VARICELLA-ZOSTER VIRUS STRAIN OKA/MERCK LIVE ANTIGEN